EIF4G1 and adenocarcinoma: The expression of EIF4G1 was significantly higher in sarcomatoid carcinoma, but there was no significant difference in other NSCLC (adenocarcinoma, squamous carcinoma, large cell carcinoma and adenosquamous carcinoma).